Global Irreversible Electroporation Ablators Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Irreversible electroporation is a soft tissue ablation technique using ultra short but strong electrical fields to create permanent and hence lethal Nano pores in the cell membrane, to disrupt the cellular homeostasis. The resulting cell death results from apoptosis and not necrosis as in all other thermal or radiation based ablation techniques. The main use of IRE lies in tumor ablation in regions where precision and conservation of the extracellular matrix, blood flow and nerves are of importance. The technique is in an experimental stage and has not been approved for use outside of clinical trials. IRE is used in the NanoKnife System.
According to our (Global Info Research) latest study, the global Irreversible Electroporation Ablators market size was valued at USD 27 million in 2022 and is forecast to a readjusted size of USD 48 million by 2029 with a CAGR of 8.7% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The world's leading manufacturers of irreversible electroporation ablators are AngioDynamics and Pulse Biosciences. North America is the largest consumption place, with a consumption market share nearly 56%. Following North America, Europe is the second largest consumption place with the consumption market share of 25%.
This report is a detailed and comprehensive analysis for global Irreversible Electroporation Ablators market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Irreversible Electroporation Ablators market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K USD/Unit), 2018-2029
Global Irreversible Electroporation Ablators market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K USD/Unit), 2018-2029
Global Irreversible Electroporation Ablators market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (K USD/Unit), 2018-2029
Global Irreversible Electroporation Ablators market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (K USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Irreversible Electroporation Ablators
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Irreversible Electroporation Ablators market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AngioDynamics and Pulse Biosciences.. etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Irreversible Electroporation Ablators market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
    Generator
    Part
    Service
Market segment by Application
    Liver
    Pancreas
    Prostate
    Others
Major players covered
    AngioDynamics
    Pulse Biosciences
Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Irreversible Electroporation Ablators product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Irreversible Electroporation Ablators, with price, sales, revenue and global market share of Irreversible Electroporation Ablators from 2018 to 2023.
Chapter 3, the Irreversible Electroporation Ablators competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Irreversible Electroporation Ablators breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Irreversible Electroporation Ablators market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Irreversible Electroporation Ablators.
Chapter 14 and 15, to describe Irreversible Electroporation Ablators sales channel, distributors, customers, research findings and conclusion.